Comparative Antioxidant Efficacy of Green-Synthesised Selenium Nanoparticles From Pongamia pinnata, Citrus sinensis, and Acacia auriculiformis: An In Vitro Analysis.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. In-vitro and In-silico Evaluation of Supercritical Extract of Acacia Auriculiformis against Breast Cancer.Cell biochemistry and biophysics · 2026
   Article
2. Antioxidant properties and antimicrobial activity of selenium nanoparticles synthetized via Zambian medicinal herbs.PloS one · 2025
   Article
3. Comparative In Vitro and In Silico Analyses of Phytochemicals From Butea monosperma for Wound-Healing Potential in Human Cells.Cureus · 2024
   Article
4. A Systematic Review on Green Synthesized Selenium Nanoparticles as Antioxidant and Antidiabetic Agents: Mechanistic Insights and Therapeutic Potential.Avicenna journal of medical biotechnology
   Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

5 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as